Advanced Proteome Therapeutics Corporation reported earnings results for the first quarter ended October 31, 2022. For the first quarter, the company reported net loss was USD 0.209712 million compared to net income of USD 0.675847 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to basic earnings per share from continuing operations of USD 0.02 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | -.--% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 150K | |
+137.37% | 5.68B | |
+1.89% | 1.01B | |
+2.19% | 982M | |
+41.91% | 872M | |
+25.27% | 819M | |
+1.68% | 663M | |
+0.54% | 610M | |
-.--% | 600M | |
+21.31% | 552M |
- Stock Market
- Equities
- APC.H Stock
- News Advanced Proteome Therapeutics Corporation
- Advanced Proteome Therapeutics Corporation Reports Earnings Results for the First Quarter Ended October 31, 2022